Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
130.5 USD | +0.18% | +2.35% | +19.71% |
05-09 | Merck Says Health Canada Approve Keytruda Combination in Biliary Tract Carcinoma | MT |
05-09 | Sector Update: Health Care Stocks Steady Pre-Bell Thursday | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+19.71% | 330B | |
+31.18% | 695B | |
+26.51% | 568B | |
-4.62% | 361B | |
+3.87% | 283B | |
+16.70% | 239B | |
+8.78% | 204B | |
-7.93% | 198B | |
+8.96% | 168B | |
+5.09% | 125B |
- Stock Market
- Equities
- MRK Stock
- News Merck & Co., Inc.
- Lava Therapeutics to Study Gammabody Combined With Merck's Keytruda to Treat Metastatic Prostate Cancer